Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India.

Jana D, Mandal S, Mukhopadhyay M, Mitra D, Mukhopadhyay SK, Sarkar DK.

Asian Pac J Cancer Prev. 2012;13(8):3851-5.

PMID:
23098482
[PubMed - indexed for MEDLINE]
Free Article
2.

Role of nuclear factor-κB in female breast cancer: a study in Indian patients.

Jana D, Das S, Sarkar DK, Mandal S, Maji A, Mukhopadhyay M.

Asian Pac J Cancer Prev. 2012;13(11):5511-5.

PMID:
23317209
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.

PMID:
19256737
[PubMed - indexed for MEDLINE]
Free Article
4.

Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India.

Zubeda S, Kaipa PR, Shaik NA, Mohiuddin MK, Vaidya S, Pavani B, Srinivasulu M, Latha MM, Hasan Q.

Asian Pac J Cancer Prev. 2013;14(4):2231-5.

PMID:
23725118
[PubMed - indexed for MEDLINE]
Free Article
5.

Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.

Sharif MA, Mamoon N, Mushtaq S, Khadim MT.

J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103. doi: 02.2009/JCPSP.99103.

PMID:
19208313
[PubMed - indexed for MEDLINE]
6.

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.

Spizzo G, Obrist P, Ensinger C, Theurl I, Dünser M, Ramoni A, Gunsilius E, Eibl G, Mikuz G, Gastl G.

Int J Cancer. 2002 Apr 20;98(6):883-8.

PMID:
11948467
[PubMed - indexed for MEDLINE]
7.

Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.

Ambroise M, Ghosh M, Mallikarjuna VS, Kurian A.

Asian Pac J Cancer Prev. 2011;12(3):625-9.

PMID:
21627355
[PubMed - indexed for MEDLINE]
Free Article
8.

Do we need HER-2/neu testing for all patients with primary breast carcinoma?

Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.

Cancer. 2003 Dec 15;98(12):2547-53.

PMID:
14669272
[PubMed - indexed for MEDLINE]
Free Article
9.

FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.

PMID:
17671124
[PubMed - indexed for MEDLINE]
Free Article
10.

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ.

J Natl Cancer Inst. 2003 Jan 15;95(2):142-53.

PMID:
12529347
[PubMed - indexed for MEDLINE]
Free Article
11.

Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis.

Sanpaolo P, Barbieri V, Pedicini P, Fusco V.

Med Oncol. 2012 Jun;29(2):459-65. doi: 10.1007/s12032-011-9869-0. Epub 2011 Feb 26.

PMID:
21359639
[PubMed - indexed for MEDLINE]
12.

c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.

Quaranta M, Daniele A, Coviello M, Savonarola A, Abbate I, Venneri MT, Paradiso A, Stea B, Zito A, Labriola A, Schittulli F.

Tumori. 2006 Jul-Aug;92(4):311-7.

PMID:
17036522
[PubMed - indexed for MEDLINE]
13.

Association of HER-2/neu overexpression with the number of involved axillary lymph nodes in hormone receptor positive breast cancer patients.

Tokatli F, Altaner S, Uzal C, Ture M, Kocak Z, Uygun K, Bilgi S.

Exp Oncol. 2005 Jun;27(2):145-9. Erratum in: Exp Oncol. 2005 Dec;27(4):346. Fusun, Tokatli [corrected to Tokatli, Fusun]; Semsi, Altaner [corrected to Altaner, Semsi]; Cem, Uzal [corrected to Cem, Uzal]; Mevlut, Ture [corrected to Ture, Mevlut]; Zafer, Kocak [corrected to Kocak, Zafer] Kazim, Uygun [corrected to Uygun, Kazim]; Selcuk, Bilgi [corrected to Bilgi, Selcuk].

PMID:
15995634
[PubMed - indexed for MEDLINE]
14.

Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.

Francis G, Beadle G, Thomas S, Mengersen K, Stein S.

Pathology. 2006 Oct;38(5):391-8.

PMID:
17008275
[PubMed - indexed for MEDLINE]
15.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
[PubMed - indexed for MEDLINE]
16.

Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.

Nyagol J, Nyong'o A, Byakika B, Muchiri L, Cocco M, de Santi MM, Spina D, Bellan C, Lazzi S, Kostopoulos I, Luzi P, Leoncini L.

Anal Quant Cytol Histol. 2006 Apr;28(2):97-103.

PMID:
16637512
[PubMed - indexed for MEDLINE]
17.

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

Breast Cancer Res. 2009;11(1):R11. doi: 10.1186/bcr2230. Epub 2009 Feb 24.

PMID:
19239686
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Her-2/neu and topoisomerase IIα in advanced breast cancer: a comprehensive FISH analysis of 245 cases.

Engelstaedter V, Schiffers J, Kahlert S, Mainka P, Engel J, Kirchner T, Diebold J, Mayr D.

Diagn Mol Pathol. 2012 Jun;21(2):77-83. doi: 10.1097/PDM.0b013e31823b6e43.

PMID:
22555090
[PubMed - indexed for MEDLINE]
19.

Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.

Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.

Breast J. 2005 Jul-Aug;11(4):278-80.

PMID:
15982396
[PubMed - indexed for MEDLINE]
20.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk